Literature DB >> 15015641

Dynamic expression of bFGF and TGFbeta2 in glomus cell grafts of carotid body in rat model of Parkinson disease.

Xuebing Cao1, Shenggang Sun, Hongtao Liu, E'tang Tong, Huisheng Xia.   

Abstract

To investigate the changes in the expression of basic fibroblast growth factor (bFGF) and transforming growth factor beta 2 (TGFbeta2) in glomus cell grafts of carotid body in the rat model of 6-hydroxydopamine-induced Parkinson disease, immunohistochemical staining of bFGF and TGFbeta2 in the sections of striate body was done on the 2nd, 4th and 12th week after transplantation. The results showed that on the 2nd week after transplantation, bFGF and TGFbeta2 were not detectable in the glumous cell grafts. On the 4th week after graft, bFGF and TGFbeta2 immunoreactivity was increased within the grafts and at the graft-host interface but was restricted only to astrocytes. In the striatum surrounding the graft, bFGF was expressed persistently, while TGFbeta2 showed transient expression. It was suggested that the transient expression of TGFbeta2 was likely due more to the trauma imposed by the graft procedure than to an intrinsic. The deficiency in astrocytic bFGF early after graft may be responsible for the poor survival of grafted glomus cells of carotid body.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15015641     DOI: 10.1007/BF02829423

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  10 in total

1.  Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates.

Authors:  E F Espejo; R J Montoro; J A Armengol; J López-Barneo
Journal:  Neuron       Date:  1998-02       Impact factor: 17.173

Review 2.  Auto transplants for Parkinson's disease?

Authors:  A Rosenthal
Journal:  Neuron       Date:  1998-02       Impact factor: 17.173

3.  Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.

Authors:  N Törnqvist; L Björklund; P Almqvist; L Wahlberg; I Strömberg
Journal:  Exp Neurol       Date:  2000-07       Impact factor: 5.330

4.  Transforming growth factor-beta 2 both stimulates and inhibits neurogenesis of rat cerebellar granule cells in culture.

Authors:  C J Kane; G J Brown; K D Phelan
Journal:  Brain Res Dev Brain Res       Date:  1996-10-23

5.  Paraneuronal grafts in unilateral 6-hydroxydopamine-lesioned rats: morphological aspects of adrenal chromaffin and carotid body glomus cell implants.

Authors:  J T Hansen; G Y Bing; M F Notter; D M Gash
Journal:  Prog Brain Res       Date:  1988       Impact factor: 2.453

6.  Temporo-spatial expression of bFGF and TGFbeta2 in embryonic dopaminergic grafts in a rat model of Parkinson's disease.

Authors:  C Sommer; M Sabel; W H Oertel; M Kiessling; J Sautter
Journal:  Brain Res Mol Brain Res       Date:  1999-05-21

7.  Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.

Authors:  C W Shults; J Ray; K Tsuboi; F H Gage
Journal:  Brain Res       Date:  2000-11-17       Impact factor: 3.252

Review 8.  Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

Authors:  G J Siegel; N B Chauhan
Journal:  Brain Res Brain Res Rev       Date:  2000-09

9.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--I. Effects in vitro.

Authors:  E Mayer; S B Dunnett; R Pellitteri; J W Fawcett
Journal:  Neuroscience       Date:  1993-09       Impact factor: 3.590

10.  TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity.

Authors:  K Krieglstein; C Suter-Crazzolara; W H Fischer; K Unsicker
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

  10 in total
  1 in total

Review 1.  Growth Factors in the Carotid Body-An Update.

Authors:  Elena Stocco; Silvia Barbon; Cinzia Tortorella; Veronica Macchi; Raffaele De Caro; Andrea Porzionato
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.